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Abstract 
Background: The hypothesis of an infectious etiology of the formerly named bronchiolo‑alveolar carcinoma (BAC) 
has raised controversy. We investigated tumor lung tissues from five patients with former BAC histology using high‑
throughput sequencing technologies to discover potential viruses present in this type of lung cancer. Around 180 
million single reads of 100 bases were generated for each BAC sample.
Results: None of the reads showed a significant similarity for Jaagsiekte sheep retrovirus (JSRV) and no other viruses 
were found except for endogenous retroviruses.
Conclusions: In conclusion, we have demonstrated the absence of JSRV and other known human viruses in five 
samples of well‑characterized lepidic adenocarcinoma.
© 2015 Berthet et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
The bronchiolar-alveolar cancer (BAC) in its past defi-
nition (WHO classification 1999) is a rare form of lung 
adenocarcinoma (ADC). The international WHO 2015 
classification recommends distinguishing adenocarci-
noma in  situ (AIS, formerly non-mucinous BAC) from 
invasive mucinous adenocarcinoma (IMA, formerly 
mucinous BAC) and non-mucinous lepidic predominant 
invasive adenocarcinoma of the lungs [1]. In many such 
patients, the tumor progression respects the pulmonary 
architecture and develops mainly in the terminal respira-
tory unit (lepidic growth).
The etiology of these cancers still remains unclear. Inter-
estingly, lung adenocarcinoma cancers with predominant 
lepidic pattern can be distinguished from other pulmonary 
non-small-cell carcinomas by an increased frequency of 
onset in young subjects, women, non-smokers and Asians. 
Unlike other lung adenocarcinomas, invasive mucinous 
adenocarcinomas (IMA) the first and more frequent vari-
ant of adenocarcinomas (WHO 2015) are multifocal or 
diffuse and the death is generally due to the bilateral pul-
monary spread rather than the onset of metastases.
Given the fact that these cancers are rarely metastatic, a 
replacement of the cancerous lung by an allograft is pos-
sible. Some cases of recurrence of the cancer in a trans-
planted lung (initially healthy) have led us to question 
the existence of an infectious agent capable of recoloniz-
ing the transplant itself. The hypothesis of an infectious 
etiology of the formerly named “BACs” has raised con-
troversy, which has been reopened by the observation 
that the ovine pulmonary adenocarcinoma, which shows 
some strong clinical and histological similarities with 
human “BACs”, is associated causally to the infection by 
the JSRV retrovirus (Jaagsiekte sheep retrovirus) [2–5]. 
However, in humans, molecular approaches mainly based 
on PCR technology aiming to reveal the genome of the 
JSRV virus in the patients with a bronchiolar-alveolar 
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cancer have nevertheless been mostly found negative [6, 
7].
The aim of this study was to explore more broadly the 
hypothesis of a viral etiology of invasive adenocarcinoma 
with lepidic growth by benefiting from high-throughput 
sequencing technologies. During the last decade, these 
approaches have enabled to discover and characterize 
some new viruses associated to chronic and/or acute 
human diseases [8, 9]. This is exemplified by the identifi-
cation in 2008, of the first human oncogenic polyomavi-
rus and its association with the Merkel cell carcinoma, a 
rare but aggressive skin cancer [8].
Methods
Tumor samples
Frozen tumor lung tissues were retrospectively collected 
from five patients with former “BAC” histology treated 
at the Institut Mutualiste Montsouris (Paris, France) 
between 2007 and 2011. Patient characteristics are sum-
marized in Table  1. Briefly, among these, three were 
female patients, two were never smokers and three were 
former smokers. As usually observed in this disease, the 
maximum standardized uptake values (SUVmax) during 
PET/CT scan examination of the patients showed gener-
ally low fixation values. Two of the cases with former BAC 
diagnosis showed invasive mucinous histology whereas 
three were non-mucinous. All cases were pathologically 
reviewed (EB) according to the recent WHO 2015 classifi-
cation of lung adenocarcinoma. Two supplementary cases 
of squamous cell carcinoma from two female smokers, 
obtained at the Centre Chirurgical Marie-Lannelongue 
(CCML, Le Plessis-Robinson, France) were used as nega-
tive controls in the bioinformatic analysis. The study 
was approved by the local ethics committee and written 
informed consents were obtained for all patients included.
Samples associated with known human oncogenic viruses
The sensibility of the high-throughput sequencing assay 
used here has been evaluated in a pilot study thanks to 
the detection of HTLV-1 and HHV-8, two very different 
known oncogenic viruses associated causally to the adult 
T cell leukemia/lymphoma (ATLL) for HTLV-1 and to the 
primary effusion lymphoma (PEL) for HHV-8. These two 
oncogenic viruses were chosen because they are quite 
different according to their size (around 9 kb for HTLV-1 
vs 200 kb for HHV-8), for their genomic form in the can-
cer cells (integrated in the genome DNA for HTLV-1 and 
latent episomal for HHV-8) and more importantly for 
their number of copies present in the tumors. Indeed, 
in ATLL, one or two copies of HTLV-1 viral genome are 
integrated into each cancer cells whereas the viral load is 
much higher in PEL with around 100–300 HHV-8 copies 
by cell. Two frozen samples of uncultured ex vivo tumors 
cells were used. The first one originated from an ATLL 
associated with HTLV-1, the second one was a PEL asso-
ciated with HHV-8. The preparation of the nucleic acid, 
the sequencing process and the bio-informatics analyses 
are described in the Additional file 1.
Methodology of data analysis
Data generated for the pilot study on ATLL and PEL, 
on one hand, and for the five adenocarcinoma samples, 
on the other hand, were subjected to a series of analy-
ses described in Fig.  1. These analyses are distributed 
between a common process, described in green and 
applied to both studies, and control processes, out-
lined in pink, specific to each study. The purpose of the 
common process was to assign taxonomies to the reads 
coming from each sample. The count of these taxono-
mies should help to identify (1) the expected viruses 
for the pilot study, (2) an infectious agent present in 
AIS nucleic acid in the main study. More details about 
the methodology of analysis are given in an Additional 
file 1.
Results
For each of the nine samples (the ATLL and the PEL 
for the pilot study and the five AIS), around 180 million 
Table 1 Patient characteristics
AT adenocarcinoma-tumor, TEP/SUVmax TEP/standardized uptake values, ADC adenocarcinoma, AIS adenocarcinoma in situ, IMA invasive mucinous adenocarcinoma, 
NMLIA non mucinous lepidic invasive adenocarcinoma
Patient number AT1 AT2 AT3 AT4 AT5
Gender Female Female Male Male Male
Age (years) 46 76 62 76 66
Smoking status Never Former Former Never Former
TEP (SUVmax) “Weak” 2.5 0 2.6 1.8
TNM pT1N0 pT2N0 TxN0 pT4N0 pT2bN0
Mucinous No Yes No No Yes
Pathological analysis NMLIA IMA Mixed AIS and minimally invasive ADC NMLIA IMA
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single reads of 100  bp were obtained while around 150 
million were obtained for the two for RNA samples (the 
ATLL and the PEL). The quality of these reads was veri-
fied and considered very good for all samples. The reads 
of each sample were filtered against the human genome 
(hg19).
Pilot study: sensibility of the detection of two 
known oncogenic viruses (HHV‑8 and HTLV‑1) 
in ex vivo tumor samples
Control specific process
The presence of both HTLV-1 and HHV-8 was searched 
in each of the four studied samples (Table  2). This was 
done either by mapping reads to reference genomes 
using bowtie2 [10], or by searching a similarity between 
the contigs/singlets and the reference genomes using 
blastn [11] (Table 2; Fig. 1a). Concerning the PEL sample, 
numerous reads originating from the DNA or the RNA 
corresponded to the HHV-8 reference genome. Indeed, a 
total of 176,000 (31 %) to 228,000 (45 %) reads were iden-
tified as deriving from the HHV-8 genome (Table 2). In 
contrast, in this PEL sample, not a single HTLV-1 read 
was found (Table  2). The HHV-8 genome is covered 
at 85–92  % by the contigs stem from the assembly step 
(Additional file  1: Figures S1 and S2). Concerning the 
ATLL sample, the results were very different as only 215 
(0.06 %) and 312 (0.14 %) reads were identified, as origi-
nating from the HTLV-1 genome, in the DNA and RNA 
samples respectively. Contigs from these samples cover 
only 45–60 % of the retroviral genome (Additional file 1: 
Figures S3 and S4).
Common process
The taxonomic assignment performed by BLASTN 
(against the EMBL database) on the contigs (similar to 
those used for above in the control process) of each sam-
ple demonstrated the ability of this process to identify 
the two viruses. For the PEL sample, HHV-8 presence 
was obvious since it represents 41  % to 80  % of assign-
ments in the RNA and DNA samples respectively, after 
filtering. The background of the analysis is minimal since 
the taxonomy “Rhadinovirus” represents 100  % of viral 
taxonomies (Additional file  1: Figures S5 and S6). For 
ATL, HTLV-1 was represented by only a few number of 
small contigs, however, the analysis process also leads to 
the detection of its presence. Although viral taxonomies 
represent only 0.08–0.7 % of the assignments (Additional 
file  1: Figures S7 and S8), in this viral branch, HTLV-1 
represents 86–98  % of the reads (Additional file  1: Fig-
ures S9 and S10). These differences between HHV-8 and 
HTLV-1 results were in agreement with the theoreti-
cal prediction that takes into account the size of the two 
genomes and their number of copies per cell.
In conclusion, long contigs representing almost all 
the viral genome can be obtained with the reads gener-
ated with the DNA (Additional file  1: Figures S1–S4). 
Fig. 1 Methodology used for the pilot study (a) and the main study (b). The common process for the two studies is summarized in the green path‑
way. The specific control processes for each study are summarized in the pink pathways
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The RNA data bring more information on the expres-
sion of the viral genes in the tumor but are less “informa-
tive” for its detection and characterization because only 
small contigs representing small parts of the genome are 
obtained. Based on these data, the use of genomic DNA 
in the IMA study was considered as a good approach for 
the research of a potential infectious agent present in 
these tumors, especially if we consider that such agent 
could be a DNA virus. Indeed, up to know, almost all 
oncogenic viruses are DNA viruses with the exception of 
HCV and HTLV-1.
Adenocarcinoma study
Similarities were initially searched using blastn, between 
some known viruses and all reads of each sample with-
out any prior filtering, especially against hg19. These 
viruses were the Jaagsiekte sheep retrovirus (JSRV, Acc 
NC_001494.1), the Human herpesvirus 6B (HHV6B, Acc 
AB021506), Epstein–Barr virus (EBV, Acc M80517) and 
the Human endogenous retrovirus K113 (HERV-K113, 
Acc AY037928). None of the reads in the five samples 
showed a significant similarity for JSRV, HHV6 and EBV. 
In contrast and, as expected, HERV was present in all the 
samples, with more than 50,000 reads per samples over-
lapping the entire HERV genome.
For control process, the filtering of five tumor samples 
allowed us to significantly reduce the number of human 
reads and contaminants (Table 1). Indeed, 62–91 % of the 
reads, remaining after hg19 filtering, were removed by 
this second filter using the two control samples (Table 3). 
Although the percentage of filtered reads is high, the 
number of remaining reads for each sample were variable 
with a maximum range from 0.3 × 105 reads for sample 
AT5 to 2 × 105 for sample AT1 (Table 3).
An overall assembly of all these filtered reads allowed 
us to obtain 596 contigs (global assembly Table 3). Simi-
larities between these contigs and the sequences of the 
EMBL database (http://www.ebi.ac.uk/ena/home) were 
searched for using blast. A total of 434 significant simi-
larities led to a taxonomic assignment for the same num-
ber of contigs. These taxonomies, depicted by the krona 
software [12] were overwhelmingly eukaryotic (96  %) 
and more specifically hominidae (76  %) (Additional 
file  1: Figure S11). The remaining sequences consist of 
contigs, shorter than 200 bases, with small similarities 
(30–40 bases) with sequences annotated as vectors (in 
green in Additional file  1: Figure S11). The taxonomic 
assignment provided by blastx against Uniprot databases 
(http://www.uniprot.org/) were almost identical (data not 
shown).
For 16 contigs, all from the AT2 sample, taxonomic 
assignment obtained by similarities close to 100  % is 
unexpected. These taxonomies refer to sequences from 
Mus musculus and never described in human sequences. 
A total of 12 contigs covering the entire CDS and the 3′ 
untranslated region of a LINE-1 sequence (L1spa Acc 
Table 2 Results of the control and the common processes of the pilot study on the PEL and ATLL samples ex‑vivo samples
Pilot study
PEL ATLL
Samples HHV-8 RNA HHV-8 DNA HTLV-1 RNA HTLV-1 DNA
HiSeq2000 run Total reads 144,170,345 118,055,719 171,301,521 154,800,548
Quality and hg19 filtersRemaining reads 500,318 566,619 226,120 375,503
Control process
 Mapping (bowtie2) Nber of reads vs HHV‑8 
genomes
227,842 (45 %) 175,905 (31 %) 0 (0 %) 0 (0 %)
Nber of reads vs HTLV‑1 
genomes
0 (0 %) 0 (0 %) 321 (0.14 %) 215 (0.06 %)
 Similarity (blastn) Contigs similar to HHV‑8. 
Genome covered by 
contigs (%)
22/1412 contigs (85 %) 11/5080 contigs (92 %) 0/1112 contigs (0 %) 0/5463 contigs (0 %)
Contigs similar to HTLV‑1. 
Genome covered by 
contigs (%)
0/1412 contigs (0 %) 0/5080 contigs (0 %) 12/1112 contigs (60 %) 9/5463 contigs (45 %)
Common process




118/1412 (8 %), 21,807 
bases (4.5 %)
615/5080 (12 %), 173,474 
bases (9 %)
141/1112 (13 %), 25,388 
bases (9 %)
698/5463 (13 %), 
214,796 bases (10 %)
Taxonomy count 41 % viruses including 
100 % Rhadinovirus
80 % viruses including 
100 % Rhadinovirus
0.7 % viruses including 
98 % HTLV‑1
0.08 % viruses including 
86 % HTLV‑1
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AF016099.1, L1Md-tf23 Acc AF081110); three contigs 
partially overlap the Gag/pol region of an intracister-
nal A-particle sequence (MIA14, Acc M17551.1) and 
one contig, the only one with high coverage, is identi-
cal to a sequence described as a major satellite repeat 
sequence (Acc EF028077). To our knowledge, these three 
sequences have not been interconnected in a database 
sequence or in a publication but all three are annotated 
as mobile elements.
Discussion and conclusion
The goal of our study was to search for the presence of 
a virus in well-characterized ex vivo samples of human 
lung adenocarcinoma, especially in the bronchiolar-
alveolar subtype. We specifically focused our study on 
these relatively rare tumors because: (1) Based on clini-
cal aspects, the hypothesis of an infectious etiology 
has been raised in such tumors. (2) The ovine pulmo-
nary adenocarcinoma which exhibits some similarities 
with mucinous BAC (now IMA) is considered causally 
associated with the JSRV retrovirus. (3) The published 
data concerning the detection by molecular means and/
or by immuno-histochemistry of such a retrovirus in 
mucinous BAC still remained controversial. Indeed, the 
most recent report focusing specifically on the JSRV 
candidate in histological sections of different lung can-
cers, including BAC, found minor evidence of JSRV 
env-specific immunoreactivity and JSRV-like env and 
gag sequence amplification. The authors suggest that 
a JSRV-like virus might infect human lungs and have 
oncogenic properties in several subtypes of lung can-
cer [13]. Conversely, other studies have failed at show-
ing any association between lung cancer and JSRV [6, 
7, 14]. Moreover, a large study recently investigated 225 
cases of lung adenocarcinomas using RNA-Seq found 
no DNA virus transcript [15].
Thus, firstly in order to try to resolve the above-dis-
cussed controversy concerning the association of JSRV 
with mucinous BAC and secondly to uncover in such 
specific lung tumors any other known or unknown 
viruses, we used the high-throughput sequencing 
method. Such assay is based on random sequencing of 
nucleic acid present in a given sample. This very broad 
approach method is highly powerful, and can detect 
any known or unknown agent with a sensitivity level 
roughly equivalent to current specific PCR methods 
[16]. Furthermore, this technological approach with 
a sufficient depth of sequencing, as performed here, is 
able to confirm the absence of a suspected infectious 
agent in targeted pathologies [15, 17, 18]. Lastly, a pre-
vious study showed the effectiveness of such a method 
on samples artificially infected with low levels of known 
viruses [16].
The first step of the study was to show the effective-
ness of the use of our methodology for two human cancer 
(ATLL or PEL) samples naturally infected by two different 
oncogenic viruses respectively (HTLV-1 and HHV-8). The 
entire pilot project demonstrated a high sensitivity to our 
approach, which was thus subsequently applied to BAC 
samples. Indeed, our method allowed us to detect but also 
identify nearly the entire sequence, or large portions, of 
these two known viral genomes in the specific cancer sam-
ples. Furthermore, our data also showed good specificity 
with, on one hand, a low background noise at both viral 
and bacterial level and, on the other hand, a lack of con-
tamination between samples. Indeed, none of the HHV-8 
reads could be detected by bowtie2 or by BLASTN in the 
ATLL samples despite the fact that the samples were han-
dled together and sequenced in the same flow cell.
Our study has several limitations:
1. This study was conducted in only 5 European 
patients.
2. There were no AIS (pure lepidic growth pattern) 
included in this study.
3. Some interesting microbial sequences, especially of 
viral origin but wrongly considered as belonging to 
(or assigned to) Homo sapiens, could have been elim-
inated through the filtering process.
4. A relatively high number of contigs (162), represent-
ing more than 300,00 bp, remained without any taxo-
nomic assignation at the end of our analyses. It could 
be hypothesized that one, or few of them, could cor-
respond to a part of a yet unknown infectious agent. 
Clarifying this situation will need further in depth 
studies searching for possible viral specific structure 
in such contigs.
5. Finally, the absence of any viral sequences in the find-
ings could be linked to the possibility of a very low viral 
load of the searched virus in only a small proportion of 
the tumor cells. Such unlikely situation has however 
been raised in some cases of Merkel cell carcinoma [8].
In conclusion, we have demonstrated the absence of 
JSRV and other known human viruses, before and after 
any filtering, in these five samples of well-characterized 
lepidic adenocarcinomas.
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